Healthcare provider profile · identity verified

Eric Allen Barr, D.O.

Family Practice · YORK, PA · NPI 1548258098

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	676	195
Levothyroxine Sodium	Levothyroxine Sodium	379	83
Amlodipine Besylate	Amlodipine Besylate	339	92
Lisinopril	Lisinopril	325	84
Metoprolol Succinate	Metoprolol Succinate	289	72
Pantoprazole Sodium	Pantoprazole Sodium	287	75
Omeprazole	Omeprazole	230	70
Valsartan	Valsartan	213	49
Furosemide	Furosemide	207	54
Rosuvastatin Calcium	Rosuvastatin Calcium	207	61
Simvastatin	Simvastatin	194	55
Gabapentin	Gabapentin	186	49
Escitalopram Oxalate	Escitalopram Oxalate	180	47
Eliquis	Apixaban	173	36
Hydrochlorothiazide	Hydrochlorothiazide	164	43
Metformin Hcl	Metformin Hcl	153	45
Tamsulosin Hcl	Tamsulosin Hcl	153	42
Prednisone	Prednisone	143	95
Lorazepam	Lorazepam	132	27
Duloxetine Hcl	Duloxetine Hcl	125	32
Sertraline Hcl	Sertraline Hcl	122	33
Alprazolam	Alprazolam	121	26
Trazodone Hcl	Trazodone Hcl	119	36
Jardiance	Empagliflozin	116	22
Albuterol Sulfate Hfa	Albuterol Sulfate	115	38
Losartan Potassium	Losartan Potassium	115	34
Carvedilol	Carvedilol	114	28
Allopurinol	Allopurinol	110	28
Bupropion Xl	Bupropion Hcl	105	22
Pravastatin Sodium	Pravastatin Sodium	105	30
Meloxicam	Meloxicam	96	23
Metoprolol Tartrate	Metoprolol Tartrate	90	27
Fluticasone Propionate	Fluticasone Propionate	87	30
Quetiapine Fumarate	Quetiapine Fumarate	83	21
Olmesartan Medoxomil	Olmesartan Medoxomil	78	20
Spironolactone	Spironolactone	77	21
Diclofenac Sodium	Diclofenac Sodium	76	24
Ozempic	Semaglutide	76	16
Glipizide Er	Glipizide	71	18
Famotidine	Famotidine	70	21
Donepezil Hcl	Donepezil Hcl	66	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	20
Zolpidem Tartrate	Zolpidem Tartrate	65	17
Clopidogrel	Clopidogrel Bisulfate	64	17
Montelukast Sodium	Montelukast Sodium	62	22
Ropinirole Hcl	Ropinirole Hcl	60	15
Farxiga	Dapagliflozin Propanediol	58	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	55	17
Atenolol	Atenolol	54	16
Celecoxib	Celecoxib	53	18
Doxycycline Hyclate	Doxycycline Hyclate	51	44
Synthroid	Levothyroxine Sodium	50	13
Alendronate Sodium	Alendronate Sodium	48	13
Potassium Chloride	Potassium Chloride	48	14
Soliqua 100-33	Insulin Glargine/Lixisenatide	48	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	46	suppressed
Telmisartan	Telmisartan	46	14
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	44	suppressed
Valacyclovir	Valacyclovir Hcl	43	17
Xarelto	Rivaroxaban	43	suppressed
Buspirone Hcl	Buspirone Hcl	41	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	suppressed
Clonazepam	Clonazepam	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	22
Paroxetine Hcl	Paroxetine Hcl	39	12
Diazepam	Diazepam	36	13
Pioglitazone Hcl	Pioglitazone Hcl	36	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Cefdinir	Cefdinir	34	30
Ezetimibe	Ezetimibe	34	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	11
Trulicity	Dulaglutide	34	suppressed
Amiodarone Hcl	Amiodarone Hcl	33	suppressed
Finasteride	Finasteride	33	suppressed
Myrbetriq	Mirabegron	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	32	26
Irbesartan	Irbesartan	32	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	31	suppressed
Tresiba Flextouch U-200	Insulin Degludec	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	24
Amoxicillin	Amoxicillin	29	15
Colesevelam Hcl	Colesevelam Hcl	29	suppressed
Fluconazole	Fluconazole	29	15
Hydroxyzine Hcl	Hydroxyzine Hcl	29	12
Mounjaro	Tirzepatide	29	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Lansoprazole	Lansoprazole	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Nifedipine Er	Nifedipine	26	suppressed
Tramadol Hcl	Tramadol Hcl	26	13
Baclofen	Baclofen	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	14
Memantine Hcl	Memantine Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Nitroglycerin	Nitroglycerin	23	12
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Cephalexin	Cephalexin	22	19
Glipizide	Glipizide	22	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Creon	Lipase/Protease/Amylase	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	18	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Rivastigmine	Rivastigmine Tartrate	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	17	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Olanzapine	Olanzapine	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Colchicine	Colchicine	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Methylphenidate Er	Methylphenidate Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Levofloxacin	Levofloxacin	13	13
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	13	suppressed
Tadalafil	Tadalafil	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Linzess	Linaclotide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Sotalol	Sotalol Hcl	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error